Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 12;13:6377–6387. doi: 10.2147/CMAR.S320490

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Mao et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The prognosis prediction role of βKlotho in PCa. (A) The Kaplan–Meier survival curve revealed the relationship between βKlotho and overall survival of PCa. (B)The Kaplan–Meier survival curve revealed the relationship between βKlotho and cancer specific survival of PCa. (C) The univariate analysis demonstrated the predictable role of different clinicopathological variables in the prognosis of PCa. (D) The multivariate analysis demonstrated the independent predictable role of βKlotho and different clinicopathological variables in the prognosis of PCa. (E) The different βKlotho expression level in subgroups classified by distant metastasis. (F) The different βKlotho expression level in subgroups classified by PSA level. *p < 0.05, **p < 0.01.

Abbreviations: PCa, prostate cancer; T, tumor; PSA, prostate-specific antigen; ELK4, ETS-like transcription factor 4.